Cost-Utility Analysis and Budget Impact Analysis of Eculizumab and Ravulizumab Compared to Plasmapheresis for Atypical Hemolytic Uremic Syndrome in Thailand

Kidney Medicine · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles